Dietary and/or physical activity interventions in women with overweight or obesity prior to fertility treatment: protocol for a systematic review and individual participant data meta-analysis
Trine Moholdt,
Rui Wang,
Ben W Mol,
Henk Groen,
Kyra Sim,
Zheng Wang,
Christina Bergh,
Joop S E Laven,
Jean-Patrice Baillargeon,
Annemieke Hoek,
Richard S Legro,
Amy E Rothberg,
Stefano Palomba,
Emily Evans-Hoeker,
Astrid E P Cantineau,
Ann Thurin‐Kjellberg,
Alexandra Dietz de Loos,
Geranne Jiskoot,
Lisa J Moran,
Juan J Espinós,
Donna Shoupe
Affiliations
Trine Moholdt
Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Trøndelag, Norway
Rui Wang
Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria, Australia
Ben W Mol
Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria, Australia
Henk Groen
Department of Epidemiology, University Medical Centre Groningen, Groningen, The Netherlands
Kyra Sim
Metabolism & Obesity Service, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
Zheng Wang
Department of Obstetrics and Gynaecology, University Medical Centre Groningen, Groningen, The Netherlands
Christina Bergh
Department of Obstetrics and Gynaecology, University of Gothenburg Sahlgrenska Academy, Gothenburg, Sweden
Joop S E Laven
Department of Obstetrics and Gynaecology, Erasmus University Medical Center, Rotterdam, Zuid-Holland, Netherlands
Jean-Patrice Baillargeon
Department of Medicine, Université de Sherbrooke, Sherbrooke, Quebec, Canada
Annemieke Hoek
Department of Obstetrics and Gynaecology, University Medical Centre Groningen, Groningen, The Netherlands
Richard S Legro
Department of Obstetrics and Gynaecology, Penn State College of Medicine, Hershey, Pennsylvania, USA
Amy E Rothberg
Department of Internal Medicine, Division of Metabolism, Endocrinology & Diabetes, University of Michigan, Ann Arbor, Michigan, USA
Stefano Palomba
Department of Obstetrics and Gynaecology, University Magna Graecia of Catanzaro, Catanzaro, Italy
Emily Evans-Hoeker
Department of Obstetrics and Gynaecology, Virginia Tech Carilion School of Medicine, Roanoke, Virginia, USA
Astrid E P Cantineau
Department of Obstetrics and Gynaecology, University Medical Centre Groningen, Groningen, The Netherlands
Ann Thurin‐Kjellberg
Department of Obstetrics and Gynaecology, University of Gothenburg Sahlgrenska Academy, Gothenburg, Sweden
Alexandra Dietz de Loos
Department of Obstetrics and Gynaecology, Erasmus University Medical Center, Rotterdam, Zuid-Holland, Netherlands
Geranne Jiskoot
Department of Obstetrics and Gynaecology, Erasmus University Medical Center, Rotterdam, Zuid-Holland, Netherlands
Lisa J Moran
Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Clayton, Victoria, Australia
Juan J Espinós
Clínica Fertty, Universidad Autónoma de Barcelona, Universidad Autónoma de Barcelona, Barcelona, Spain
Donna Shoupe
Department of Obstetrics and Gynaecology, University of Southern California Keck School of Medicine, Los Angeles, California, USA
Introduction Dietary and/or physical activity interventions are often recommended for women with overweight or obesity as the first step prior to fertility treatment. However, randomised controlled trials (RCTs) so far have shown inconsistent results. Therefore, we propose this individual participant data meta-analysis (IPDMA) to evaluate the effectiveness and safety of dietary and/or physical activity interventions in women with infertility and overweight or obesity on reproductive, maternal and perinatal outcomes and to explore if there are subgroup(s) of women who benefit from each specific intervention or their combination (treatment–covariate interactions).Methods and analysis We will include RCTs with dietary and/or physical activity interventions as core interventions prior to fertility treatment in women with infertility and overweight or obesity. The primary outcome will be live birth. We will search MEDLINE, Embase, Cochrane Central Register of Controlled Trials and trial registries to identify eligible studies. We will approach authors of eligible trials to contribute individual participant data (IPD). We will perform risk of bias assessments according to the Risk of Bias 2 tool and a random-effects IPDMA. We will then explore treatment–covariate interactions for important participant-level characteristics.Ethics and dissemination Formal ethical approval for the project (Venus-IPD) was exempted by the medical ethics committee of the University Medical Center Groningen (METc code: 2021/563, date: 17 November 2021). Data transfer agreement will be obtained from each participating institute/hospital. Outcomes will be disseminated internationally through the collaborative group, conference presentations and peer-reviewed publication.PROSPERO registration number CRD42021266201.